Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MDNA11 |
Synonyms | |
Therapy Description |
MDNA11 is a long-acting version of IL2 that selectively binds ILR2beta, which potentially enhances antitumor immune response and reduces tumor growth (PMID: 35058325). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MDNA11 | MDNA 11|MDNA-11 | MDNA11 is a long-acting version of IL2 that selectively binds ILR2beta, which potentially enhances antitumor immune response and reduces tumor growth (PMID: 35058325). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|